{
  "catalogId": "7e6b5eb2-770a-4514-ab12-1e7e9ad5d49d",
  "name": "XALKORI 200 MG",
  "status": "draft",
  "category": "prescription",
  "registrationValidity": "valid",
  "registrationNumber": "147 40 33588 00",
  "treatmentDescriptions": "XALKORI is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) that is anaplastic lymphoma kinase (ALK)-positive.  Xalkori is indicated for the treatment of patients with metastatic NSCLC whose tumors are ROS1-positive.",
  "termsOfIssue": "Prescription required",
  "form": "capsules",
  "route": "per os",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "CRIZOTINIB",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "L01XE16",
      "name": "CRIZOTINIB"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "XALKORI 250MG 60CAPS",
      "manufacturer": {
        "name": "פיזר",
        "countryOfOrigin": "IL"
      },
      "strength": {
        "value": 0,
        "unit": ""
      },
      "quantity": {
        "value": 60.0,
        "unit": "units"
      },
      "packagingDescription": "BLISTER PVC/ALUMINIUM",
      "shelfLife": "48",
      "storageConditions": "",
      "codes": {
        "moh": "6928",
        "yarpa": "20582",
        "pharmasoft": "34073",
        "barcode": "7290013592064"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": 15861.57276,
        "retailMargin": 10.0,
        "maxRetailPrice": 17447.73003,
        "maxPriceWithVAT": 20588.32052
      }
    }
  ],
  "metadata": {
    "version": "1.4",
    "lastUpdated": "2025-07-31T22:09:12.677703"
  }
}